G - Physics – 01 – N
Patent
G - Physics
01
N
G01N 33/53 (2006.01)
Patent
CA 2589277
The present invention relates to the discovery that acute-phase serum amyloid protein A (A-SAA) is a biomarker for obesity and certain abnormal conditions. The present invention, therefore, provides methods of diagnosing obesity or an abnormal condition in a subject The present invention also provides methods of monitoring the progression of obesity or an abnormal condition in a subject. The present invention also relates to treating obesity or an abnormal condition comprising reducing the levels of active SAA1 and/or SAA2 in a subject in need thereof.
L'invention concerne la découverte que la protéine sérum amyloïde A de phase aiguë (A-SAA) est un biomarqueur pour l'obésité et certains états anormaux. Par conséquent, l'invention concerne des méthodes permettant de diagnostiquer l'obésité ou un état anormal chez un sujet. L'invention concerne également des méthodes permettant de surveiller le progrès de l'obésité ou d'un état anormal chez un sujet. Enfin, l'invention concerne un traitement de l'obésité ou d'un état anormal qui consiste à réduire les taux de SAA1 active et/ou de SAA2 active chez un sujet nécessitant un tel traitement.
Fried Susan K.
Gong Da-Wei
Shuldiner Alan R.
Yang Rong-Ze
Smart & Biggar
University Of Maryland Baltimore
LandOfFree
Serum amyloid a protein in inflammation and obesity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Serum amyloid a protein in inflammation and obesity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Serum amyloid a protein in inflammation and obesity will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1408168